
Vascular Interventional Balloon Product Developer
CEC 2024
DKmedtech

Jointly hosted by the Vascular Surgery Branch of the Cross-Straits Medical and Health Exchange Association, Beijing Anzhen Hospital affiliated with Capital Medical University, the First Medical Center of the General Hospital of the People's Liberation Army, Zhongshan Hospital affiliated with Fudan University, the Vascular Medicine Committee of the Chinese Research Hospital Association, and the Beijing Borui Vascular Health Public Welfare Foundation."CEC2024 The 15th China Vascular Conference" will be held at the China National Convention Center in Beijing from October 31 to November 3, 2024.。
This year's CEC2024 will join hands with highly influential vascular surgery academic organizations/groups from both sides of the Taiwan Strait, as well as top international vascular disease academic organizations, to comprehensively showcase the latest achievements and development trends in the field of vascular surgery through featured formats such as expert keynote speeches, surgical video demonstrations, and live broadcasts of specialized surgeries.
Booth Information
Time:October 31, 2024 - November 03, 2024
Location:Fourth Floor, Beijing National Convention Center
Booth No.:B14
Advertising Space:No. 10

DK Medtech @ CEC 2024
We sincerely invite you to visit our booth and experience the latest product of DK Medtech, the DKutting® LL Directional Cutting Balloon (up to 150mm in length).Our professional team will be on-site to answer your questions, demonstrate product operations, and discuss new devices and technologies for complex endovascular treatments.
DK Medtech is committed to the research and production of balloon catheters. Through continuous innovation and development, we address clinical pain points by transforming and implementing innovative devices that effectively meet clinical needs. We aim to inject new momentum into the advancement of healthcare and promote medical innovation. We look forward to meeting you at the 2024 CEC conference to jointly embark on a new chapter of vascular intervention solutions.

